Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles

被引:154
作者
Griffith, Darren M. [1 ,2 ]
Li, Hongyan [3 ,4 ]
Werrett, Melissa, V [5 ]
Andrews, Philip C. [5 ]
Sun, Hongzhe [3 ,4 ]
机构
[1] Royal Coll Surgeons Ireland, Dept Chem, 123 St Stephens Green, Dublin 2, Ireland
[2] Synth & Solid State Pharmaceut Ctr, SSPC, Limerick, Ireland
[3] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Peoples R China
[4] Univ Hong Kong, CAS HKU Joint Lab Metall Hlth & Environm, Pokfulam Rd, Hong Kong, Peoples R China
[5] Monash Univ, Sch Chem, Melbourne, Vic, Australia
基金
英国医学研究理事会; 爱尔兰科学基金会; 澳大利亚研究理事会;
关键词
METAL-BINDING PROPERTIES; FLOW GEL-ELECTROPHORESIS; DUODENAL-ULCER PATIENTS; HISTIDINE-RICH PROTEIN; NEAR-INFRARED LIGHT; HELICOBACTER-PYLORI; IN-VIVO; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC-RESISTANCE; PHOTOTHERMAL THERAPY;
D O I
10.1039/d0cs00031k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Bismuth as a relatively non-toxic and inexpensive metal with exceptional properties has numerous biomedical applications. Bismuth-based compounds are used extensively as medicines for the treatment of gastrointestinal disorders including dyspepsia, gastric ulcers and H. pylori infections. Recently, its medicinal application was further extended to potential treatments of viral infection, multidrug resistant microbial infections, cancer and also imaging, drug delivery and biosensing. In this review we have highlighted the unique chemistry and biological chemistry of bismuth-209 as a prelude to sections covering the unique antibacterial activity of bismuth including a description of research undertaken to date to elucidate key molecular mechanisms of action against H. pylori, the development of novel compounds to treat infection from microbes beyond H. pylori and the significant role bismuth compounds can play as resistance breakers. Furthermore we have provided an account of the potential therapeutic application of bismuth-213 in targeted alpha therapy as well as a summary of the biomedical applications of bismuth-based nanoparticles and composites. Ultimately this review aims to provide the state of the art, highlight the untapped biomedical potential of bismuth and encourage original contributions to this exciting and important field.
引用
收藏
页码:12037 / 12069
页数:33
相关论文
共 293 条
[2]  
Ajiboye T.O, 2021, RESULTS CHEM, V3
[3]   Antibiotic resistance in Helicobacter pylori [J].
Alba, Claudio ;
Blanco, Ana ;
Alarcon, Teresa .
CURRENT OPINION IN INFECTIOUS DISEASES, 2017, 30 (05) :489-497
[4]  
Allen BJ, 1999, NUCL MED COMMUN, V20, P205
[5]   Preventing bacterial growth on implanted device with an interfacial metallic film and penetrating X-rays [J].
An, Jincui ;
Sun, An ;
Qiao, Yong ;
Zhang, Peipei ;
Su, Ming .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2015, 26 (02) :1-6
[6]   Impact of substituents on the crystal structures and anti-leishmanial activity of new homoleptic Bi(iii) dithiocarbamates [J].
Anamika ;
Singh, Rajan ;
Manar, Krishna K. ;
Yadav, Chote Lal ;
Kumar, Akhilesh ;
Singh, Rakesh K. ;
Drew, Michael G. B. ;
Singh, Nanhai .
NEW JOURNAL OF CHEMISTRY, 2019, 43 (43) :16921-16931
[7]   Bioactive Heteroleptic Bismuth(V) Complexes: Synthesis, Structural Analysis and Binding Pattern Validation [J].
Andleeb, Sohaila ;
Imtiaz-ud-Din ;
Rauf, Muhammad Khawar ;
Azam, Syed Sikander ;
Haq, Ihsan-ul ;
Tahir, Muhammad Nawaz ;
Ahmad, Sajjad .
APPLIED ORGANOMETALLIC CHEMISTRY, 2019, 33 (09)
[8]  
ANDREASEN JJ, 1987, ACTA PATH MICRO IM B, V95, P147
[9]   Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents [J].
Andrews, Philip C. ;
Blair, Victoria L. ;
Ferrero, Richard L. ;
Junk, Peter C. ;
Kedzierski, Lukasz ;
Peiris, Roshani M. .
DALTON TRANSACTIONS, 2014, 43 (03) :1279-1291
[10]   Making Bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate [J].
Andrews, Philip C. ;
Blair, Victoria L. ;
Ferrero, Richard L. ;
Junk, Peter C. ;
Kumar, Ish .
CHEMICAL COMMUNICATIONS, 2013, 49 (28) :2870-2872